Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Polled Review Staff On Avandia REMS Changes

Executive Summary

Decision to replace the rosiglitazone REMS’ distribution restrictions with prescriber training reflected a consensus opinion shared by leadership in three CDER offices, despite a poll of reviewers who participated in a June advisory committee meeting and favored eliminating the risk management program.

Advertisement

Related Content

FDA Replaces Avandia REMS Distribution Restrictions With Prescriber Training
Will CV Verdicts For Onglyza, Nesina Cause FDA To Change Its Tune On Antidiabetic Safety?
Shared REMS Systems Show Challenges Of Standardization – Could PDUFA V Help?
Avandia Review Endorsement Aided By Good Data, Cultural Shift On Safety
Avandia Committee Gives Split Vote To Drug, But FDA Clear Winner
GSK’s DoJ Settlement Links Executive Bonus To Continued Compliance
Avandia REMS Limits Access To Mail Order Pharmacies Beginning In November
FDA, EMA Decisions On Avandia Reflect The Power Of REMS
FDA's Marciniak vs. Unger: Cardio Experts Divided On GSK's RECORD Study
FDA Drug Review, Surveillance Offices Agree To Share Safety Authority

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS055771

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel